<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>We report a patient with a <z:hpo ids='HP_0002342'>moderate mental retardation</z:hpo>, afebrile <z:hpo ids='HP_0001250'>seizure</z:hpo>, mild dysmorphic features and type 2 <z:hpo ids='HP_0000819'>diabetes mellitus</z:hpo> with mild <z:hpo ids='HP_0001513'>obesity</z:hpo> and <z:e sem="disease" ids="C0948265" disease_type="Disease or Syndrome" abbrv="">metabolic syndrome</z:e> </plain></SENT>
<SENT sid="1" pm="."><plain>Array-CGH analysis revealed a de novo 790-830Â kb duplication on chromosome 17p13.1, not reported so far </plain></SENT>
<SENT sid="2" pm="."><plain>Among the approximately 50 genes involved in the rearrangement, neuroligin 2 (NLGN2) and ephrin B3 (EFNB3) are candidates for the <z:hpo ids='HP_0001249'>mental retardation</z:hpo> phenotype </plain></SENT>
<SENT sid="3" pm="."><plain>NLGN2 may therefore be a novel candidate gene for <z:hpo ids='HP_0001249'>mental retardation</z:hpo> or <z:e sem="disease" ids="C0524528" disease_type="Mental or Behavioral Dysfunction" abbrv="">autistic spectrum disorder</z:e>, joining other members of the neurexin/neuroligin network </plain></SENT>
<SENT sid="4" pm="."><plain>Moreover, GLUT4, a member of the solute carrier family 2, may play a role in the patient's type 2 <z:mp ids='MP_0002055'>diabetes</z:mp> </plain></SENT>
</text></document>